APS is characterized by the generation of antibodies that either bind to the phospholipid-binding protein β2 glycoprotein I (β2GPI) or directly target negatively charged membrane phospholipids (PLs) [7]. Here, APOH is linked to autoimmune polyendocrinopathy.